NovaBridge Biosciences Lessee, Operating Lease, Liability, to be Paid, Year One
NovaBridge Biosciences (NBP) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.04 million as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-04-07
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One 22.95M CNY.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One 37.87M CNY.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One 35.36M CNY.
- 2019-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One 7.63M CNY.
CNY
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2023-12-31 | 22.95M CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 37.87M CNY 20-F · filed 2023-05-01 |
| 2021-12-31 | 35.36M CNY 20-F · filed 2022-04-29 |
| 2019-12-31 | 7.63M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $1.04M 20-F · filed 2026-04-07 |
| 2025-09-30 | $1.04M 6-K · filed 2025-12-18 |
| 2025-06-30 | $1.04M 6-K · filed 2025-10-06 |
| 2024-12-31 | $1.01M 20-F · filed 2025-04-03 |
| 2023-12-31 | $3.23M 20-F · filed 2024-04-30 |
| 2022-12-31 | $5.49M 20-F · filed 2023-05-01 |
| 2021-12-31 | $5.55M 20-F · filed 2022-04-29 |
| 2019-12-31 | $1.09M 20-F · filed 2020-04-29 |